Proliferation markers are used to determine the behavior and prognoses of malignant tumors, and, in the present study, we assessed the effect of GANT61 on the proliferative potential of B16 cells in the tumor bone microenvironment by determining the percentage of tumor cells stained with proliferating cell nuclear antigen (PCNA) in the paraffin sections. This evidence concerns the gene PCNA and cancer.